Standex price target raised to $190-$200 from $180 at Barrington

Barrington raised the firm’s price target on Standex to a range of $190-$200 from $180 and keeps an Outperform rating on the shares. The company reported an in-line fiscal Q4 report and issued a solid outlook for fiscal 2025, the analyst tells investors in a research note. Standex had a solid quarter of operational performance despite continued softness in general market conditions, the analyst tells investors in a research note.